These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9131604)

  • 1. FDA launches "new use initiative".
    Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604
    [No Abstract]   [Full Text] [Related]  

  • 2. Fast track for AIDS and cancer drugs.
    Gershon D
    Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690
    [No Abstract]   [Full Text] [Related]  

  • 3. Applicability of phase I trial results in the design of phase II and III biological response modifier trials.
    Pinsky CM
    Cancer Treat Rep; 1985 Oct; 69(10):1171-3. PubMed ID: 4042095
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K
    J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine approved by FDA for treatment of AIDS.
    Clin Pharm; 1987 Jun; 6(6):431,435. PubMed ID: 3319360
    [No Abstract]   [Full Text] [Related]  

  • 6. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical quality assurance in the pharmaceutical industry.
    Donahue JJ
    Cancer Treat Rep; 1985 Oct; 69(10):1195-7. PubMed ID: 4042098
    [No Abstract]   [Full Text] [Related]  

  • 8. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introduction and consideration of the anti-cancer drug evaluation strategy in Europe and America].
    Tang JY; Ma L; Zhang L
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):798-800. PubMed ID: 19173820
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
    Tremaine WJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCI begins overhaul of late-stage cancer trials.
    Ault A
    Nat Med; 1998 Nov; 4(11):1219. PubMed ID: 9809532
    [No Abstract]   [Full Text] [Related]  

  • 13. Unproven methods of cancer treatment: H.11.
    CA Cancer J Clin; 1970; 20(3):172-5. PubMed ID: 4988623
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of probiotics as biologic drugs.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S125-7; discussion S144-51. PubMed ID: 18181717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
    Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
    J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products.
    Rock EP; Scott JA; Kennedy DL; Sridhara R; Pazdur R; Burke LB
    J Natl Cancer Inst Monogr; 2007; (37):27-30. PubMed ID: 17951228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA starts moving on critical path, but initiative running out of steam.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Mar; 99(6):426-7. PubMed ID: 17374831
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration.
    Hutchinson N; Carlisle B; Doussau A; Bosan R; Gumnit E; MacPherson A; Fergusson DA; Kimmelman J
    JAMA Netw Open; 2021 May; 4(5):e2110456. PubMed ID: 34003270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of agency component for review of premarket applications--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58754-8. PubMed ID: 10115697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symposium on quality assurance and good clinical practice (GCP) in cancer drug development.
    Kranich AL; Gastl G; Maier-Lenz H; Nagel GA
    J Cancer Res Clin Oncol; 1994; 120(10):625-7. PubMed ID: 7929536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.